Cafepharma Today

December 12 2024 - Industry M&A volume declined 8% this year compared to '23
Industry M&A volume declined 8% this year compared to '23
Pfizer's Ibrance improves survival in new breast cancer indication
Lynparza boosts long-term survival in early breast cancer
Trump says "big discussion" over childhood vaccine programs is coming
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Dr Reddy's plans to brand US speciality drugs
Business Standard, India
Sunday, August 24, 2008 - 10:32am
tags:
Antibody Engineering Cuts the Collateral Damage of Cancer Drugs
Wired News
Sunday, August 24, 2008 - 10:30am
tags:
New FDA labels may protect drug makers
The News Journal, DE
Sunday, August 24, 2008 - 10:23am
tags:
FDA Approves ALOXI(R) (Palonosetron HCl) Capsules For Prevention Of Acute Chemotherapy Induced Nausea And Vomiting
Medical News Today
Sunday, August 24, 2008 - 10:22am
tags:
Long Uphill Climb Continues For Genetics Firms
Yahoo/Investors Business Daily
Saturday, August 23, 2008 - 2:07pm
tags:
Don't Worry About Vytorin's Cancer Risk
Motley Fool
Saturday, August 23, 2008 - 10:47am
tags:
Salix Pharmaceuticals Sells $60 Million Of Convertible Notes
Trading Markets
Saturday, August 23, 2008 - 10:43am
tags:
GSK to provide public with more information
San Antonio Business Journal, TX
Saturday, August 23, 2008 - 10:42am
tags:
PharmaGap Closes $1.1 million Public Portion of Anticipated $2.6 million Equity Financing; Announces Full Clinical Development Group to Take Lead Cancer Drug into Human Clinical Trials
CNW Telbec
Saturday, August 23, 2008 - 10:41am
tags:
Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
CNW Telbec, Canada
Saturday, August 23, 2008 - 10:39am
tags:
FDA wants clear drug labels
Allentown Morning Call, PA
Saturday, August 23, 2008 - 10:37am
tags:
Owning Abbott shares a 'badge of honor'
Waukegan News Sun, IL
Saturday, August 23, 2008 - 10:35am
tags:
Cymbalta Receives European Approval For The Treatment Of Generalised Anxiety Disorder
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
Indevus Pharmaceuticals Announces Completion Of Enrollment In Phase III Trial Of PRO 2000
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
FDA Needs Nine More Months to Study Vytorin, Cancer Link
MedHeadlines
Saturday, August 23, 2008 - 10:30am
tags:
Health Winners & Losers: Alpharma
Yahoo/TheStreet.com
Friday, August 22, 2008 - 7:23pm
tags:
BioMarin Pharmaceutical shares rise on long-term outlook for genetic disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 7:22pm
tags:
FDA rule on drug labeling attracts praise from drugmakers, ire from lawyers
Yahoo/AP
Friday, August 22, 2008 - 7:21pm
tags:
Pharma Deals: Start Hostile. Get Friendly.
WSJ Online
Friday, August 22, 2008 - 7:20pm
tags:
King Pharma raises pressure on rival
Financial Times
Friday, August 22, 2008 - 7:19pm
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

White Bagging Update 2024: Providers’ Pushback Preserves Buy-and-Bill (rerun)
Drug Channels
Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (rerun)
Drug Channels
Bad Bar Graphs
In the Pipeline
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating (rerun)
Drug Channels
Infant RSV Vaccination Trouble
In the Pipeline
The BioSecure Act Falters?
In the Pipeline
Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble? (rerun)
Drug Channels
Computational Care
In the Pipeline
The Rings Less Traveled
In the Pipeline

Latest Jobs

Virtual Biopharma Sales Specialist
Raleigh, North Carolina, 27601
Syneos Health/ inVentiv Health Commercial LLC
Pharmaceutical Sales Customer Engagement - Santa Rosa, CA
Santa Rosa, California,
Otsuka
Portfolio Sales Specialist - North Dakota / South Dakota / Nebraska
Lincoln, Nebraska, 68511
ICU Medical
Bilingual Business Development Representative
Kennedy Space Center, Florida
Complete Care
Business Development Manager, Facial - Chevy Chase, MD
Chevy Chase, Maryland, 20815
AbbVie
Virtual Biopharma Sales Specialist
Dallas, Texas, 75215
Syneos Health/ inVentiv Health Commercial LLC
Regional Director, Central Baltimore, Maryland, United States
Baltimore, Maryland, 21276
TBWA\Chiat\Day
Account Executive
San Antonio, Texas, 78208
Elara Caring
Nobel Biocare Regional Manager - Mid Atlantic
Washington, District of Columbia, 20022
enVista
Senior Manager, Professional Affairs (Northeast)
Jersey City, New Jersey, 07390
Bausch + Lomb
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information